Monthly Archives: December 2023

Community Pharmacy Surrey and Sussex worked with NHS Sussex to develop a pathway to maximise the use of the Hypertension Case-Finding Service to increase the detection rate of undiagnosed hypertension. The pathway was developed using a digital communication platform and bespoke secure messages to patients. The initiative, utilising digital tools and messaging, facilitated collaborative working [...]

The post Service case study: Identification of undiagnosed hypertension appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/12/2023) announced the following list of price concessions for December 2023. Community Pharmacy England has received a large number of reports of products not available at their Drug [...]

The post December 2023 Price Concessions 2nd Update appeared first on Community Pharmacy England.

NHS England has published the final 23 Patient Group Directions (PGDs) and protocol for the Pharmacy First service, which is due to start on 31st January 2024. Draft versions of the PGDs and protocols were published on the NHS Business Services Authority’s website on 1st December 2023, to help pharmacists and pharmacy owners to start [...]

The post Pharmacy First: Final PGDs and protocol published appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Glucagon (GlucaGen®) 1mg powder for injection kit . MSN/2023/051 Tier 2 – medium impact Date of issue 18th December 2023 There are two licensed glucagon preparations: GlucaGen® (1mg powder for injection kit) and Ogluo® (0.5mg and 1mg pre-filled auto-injector pens) There [...]

The post Medicine Supply Notification: Glucagon (GlucaGen®) 1mg powder for injection kit appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/116 Tier 2 – medium impact Date of issue 18th December 2023 Oxybutynin 5mg modified-release tablets are out of stock until early April 2024. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support increased [...]

The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on Community Pharmacy England.